<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00265252</url>
  </required_header>
  <id_info>
    <org_study_id>fosamax 01</org_study_id>
    <nct_id>NCT00265252</nct_id>
  </id_info>
  <brief_title>Alendronate in the Prevention of Collapse of Femoral Head in Non-Traumatic Osteonecrosis</brief_title>
  <official_title>Alendronate in the Prevention of Collapse of Femoral Head in Non-Traumatic Osteonecrosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kaohsiung Medical University Chung-Ho Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Cheng-Kung University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Kaohsiung Medical University Chung-Ho Memorial Hospital</source>
  <brief_summary>
    <textblock>
      To determine the cumulative incidence of total hip replacement, time to event after treatment
      with Fosamax or placebo during the study peroid
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To determine the cumulative incidence of total hip replacement and collpase of femoral head,
      time to event after treatment with Fosamax or placebo during the study peroid
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>June 2005</start_date>
  <completion_date type="Anticipated">June 2008</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the cumulative of total hip replacement</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>necrotic area</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Harris hip score</measure>
  </secondary_outcome>
  <enrollment>60</enrollment>
  <condition>Non-Traumatic Osteonecrosis</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Alendronate</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  osteonecrosis of femoral head

          -  be able to provide singed informed consent

        Exclusion Criteria:

          -  prior bisphosphonate use

          -  pregnant or lactating woman

          -  bilateral hip replacement
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gwo-Jaw Wang, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Kaohsiung Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kaohsiung Medical University Chung-Ho Memorial Hospital</name>
      <address>
        <city>Kaohsiung</city>
        <zip>807</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Lai KA, Shen WJ, Yang CY, Shao CJ, Hsu JT, Lin RM. The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. J Bone Joint Surg Am. 2005 Oct;87(10):2155-9.</citation>
    <PMID>16203877</PMID>
  </reference>
  <verification_date>April 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2005</study_first_submitted>
  <study_first_submitted_qc>December 12, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2005</study_first_posted>
  <last_update_submitted>February 26, 2008</last_update_submitted>
  <last_update_submitted_qc>February 26, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 27, 2008</last_update_posted>
  <keyword>osteonecrosis</keyword>
  <keyword>total hip replacement</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteonecrosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alendronate</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>May 4, 2015</submitted>
    <returned>May 19, 2015</returned>
    <submitted>March 15, 2017</submitted>
    <returned>April 26, 2017</returned>
    <submitted>June 11, 2017</submitted>
    <returned>February 1, 2018</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

